Glickman Mark A 4
4 · NeuroBo Pharmaceuticals, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Glickman Mark A
Director
Transactions
- Award
Common Stock
2024-06-07+5,051→ 9,740 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units issued to the Reporting Person under the Issuer's 2022 Equity Incentive Plan, which vests on the earlier of June 7, 2025 or the day immediately prior to the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continuing service on the applicable vesting date.
- [F2]The total number of securities beneficially owned has been adjusted to reflect the Issuer's completion of a 1-for-8 reverse stock split on December 20, 2023.